Pegylated interferon in the treatment of chronic delta hepatitis: the experience from real-world clinical practice

Pegylated interferon in the treatment of chronic delta hepatitis: the experience from real-world clinical practice

Rationale: The high prevalence of hepatitis D virus (HDV) infection in the Republic of Dagestan, significantly exceeding that in the European part of the Russian Federation, as well as the limited choice of therapeutic options, have led to the need to analyze the accumulated experience of interferon...

Full description

Bibliographic Details
Main Authors: Saniyat A. Magomedova, Saida K. Bilalova, Khatuna D. Peradze, Olga V. Isaeva, Vera S. Kichatova, Elena Y. Malinnikova, Liudmila Y. Ilchenko, Karen K. Kyuregyan, Vasiliy G. Akimkin, Mikhail I. Mikhailov
Format: Article
Language:Russian
Published: MONIKI 2023-10-01
Series:Alʹmanah Kliničeskoj Mediciny
Subjects:
hepatitis delta
pegylated interferon alpha
virological response
biochemical response
safety
Online Access:https://almclinmed.ru/jour/article/viewFile/15280/1588

Internet

https://almclinmed.ru/jour/article/viewFile/15280/1588

Similar Items